Search Results 211-220 of 13262 for Assay

  1. Drug Used for Blood Cancers May Stop Spread of Breast Cancer Cells, Mayo Clinic Finds

    Borges also developed an assay that can be used to measure the amount of PRKD1 that is silenced in patients' breast tumors. "Because we found that PRKD1 is ...

  2. Donor-derived Cell Free DNA as a Tissue Injury Marker for Early Detection of Acute Rejection and Development of CLAD Following Lung Transplantation in Adults - Mayo Clinic

    The aim of this study is to evaluate a novel NGS-based assay for early detection of increased amounts of dd-cfDNA and its correlation to acute graft ...

  3. Kidney Stone Status in Waste Nephrectomy Samples Specific Tubular and Interstitial Cellular Protein and Gene Expressions - Mayo Clinic

    ... assay transposase accessible chromatin (ATAC), cellular indexing of transcriptomes and epitomes (CITE), and RNA expression and protein (REAP) sequencing ...

  4. A Study of the Use of Quantiferon CMV Blood Test to Find the Length of CMV Prevention in CMV Donor (+) / Recipient (-) Solid Organ Transplant Recipients - Mayo Clinic

    Our hypothesis is that in CMV D+/R- solid organ transplant recipients, the development of immunity as measured by a positive QuantiFERON CMV assay will predict ...

  5. A Study to Assess the Updated Prospera™ Diagnostic Test - Mayo Clinic

    Natera has developed an assay called Prospera™ to detect the amount of donor-derived cell-free DNA (dd-cfDNA), which is a marker of kidney rejection.

  6. Overview - Renovascular Disease Laboratory - Mayo Clinic Research

    Exploring novel disease mechanisms. Our lab uses cutting-edge assays to evaluate the pathophysiology of kidney disease.

  7. Prospective multicenter study tests combination of pancreatic juice and blood-based biomarkers to facilitate early pancreatic cancer detection - Mayo Clinic

    Majumder and colleagues are developing a liquid biopsy approach for detecting PDAC using methylated DNA markers assayed in secretin-stimulated pancreatic juice ...

  8. RenaCARE - Mayo Clinic

    The purpose of this study is to evaluate the Renasight™ test, a next generation sequencing (NGS) gene mutation assay, for patients with chronic kidney ...

  9. Role of Alpha-Synuclein Oligomers in Disease - Neurobiology of Parkinson's Disease Laboratory - Mayo Clinic Research

    This assay allows rapid screening of modifications and therapeutic agents that target the oligomeric stage of fibrillization. This is where rescue of the ...

  10. Extracellular Vesicle Cargo During Type 1 Diabetes Progression - Mayo Clinic

    The study also aims to test protocols for efficient isolation of plasma-derived EXO from small volumes of sample, develop an assay for the sensitive ...